To investigate the biological immune impact of SAA, we introduced recombinant SAA and α-SAA neutralization antibody into an ex-vivo tumor organoids-PBMCs (peripheral blood mononuclear cell) model. This evidence concerns the gene SAA1 and neoplasm.